VITALISScE
This study is open to adults aged 18 and older or above legal age who have systemic sclerosis. People can participate if they have a specific subtype called diffuse cutaneous systemic sclerosis. People with another subtype called limited cutaneous…
- Investigator
- Michael R Bubb
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
A multicenter, open-label extension study to assess the long-term safety and tolerability of dapirol
The purpose of this study is to evaluate long-term safety and tolerability of dapirolizumab pegol treatment.
- Investigator
- Michael R Bubb
- Status
- Accepting Candidates
- Ages
- 16 Years - N/A
- Sexes
- All
OCEAN
- Investigator
- Michael R Bubb
- Status
- Accepting Candidates